skip to main content
Idioma:
Refinado por: Nome da Publicação: Cancer remover nível superior: Revistas revisadas por pares remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Blastic plasmacytoid dendritic cell neoplasm (BPDCN): A promising future in the era of targeted therapeutics
Blastic plasmacytoid dendritic cell neoplasm (BPDCN): A promising future in the era of targeted therapeutics
Material Type:
Artigo 		Adicionar ao Meu Espaço

Blastic plasmacytoid dendritic cell neoplasm (BPDCN): A promising future in the era of targeted therapeutics

Adimora, Ijele J. ; Wilson, Nathaniel R. ; Pemmaraju, Naveen

Cancer, 2022-08, Vol.128 (16), p.3019-3026 [Periódico revisado por pares]

Atlanta: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
2
A phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancer
A phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancer

Amato, Robert J. ; Jac, Jaroslaw ; Giessinger, Sarah ; Saxena, Somyata ; Willis, James P.

Cancer, 2009-06, Vol.115 (11), p.2438-2446 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
3
A phase 1 study of the pan‐bromodomain and extraterminal inhibitor mivebresib (ABBV‐075) alone or in combination with venetoclax in patients with relapsed/refractory acute myeloid leukemia
A phase 1 study of the pan‐bromodomain and extraterminal inhibitor mivebresib (ABBV‐075) alone or in combination with venetoclax in patients with relapsed/refractory acute myeloid leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase 1 study of the pan‐bromodomain and extraterminal inhibitor mivebresib (ABBV‐075) alone or in combination with venetoclax in patients with relapsed/refractory acute myeloid leukemia

Borthakur, Gautam ; Odenike, Olatoyosi ; Aldoss, Ibrahim ; Rizzieri, David A. ; Prebet, Thomas ; Chen, Chris ; Popovic, Relja ; Modi, Dimple A. ; Joshi, Rujuta H. ; Wolff, Johannes E. ; Jonas, Brian A.

Cancer, 2021-08, Vol.127 (16), p.2943-2953 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
4
A phase 2 study of epothilone B analog BMS‐247550 (NSC 710428) in patients with relapsed aggressive non‐Hodgkin lymphomas
A phase 2 study of epothilone B analog BMS‐247550 (NSC 710428) in patients with relapsed aggressive non‐Hodgkin lymphomas
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase 2 study of epothilone B analog BMS‐247550 (NSC 710428) in patients with relapsed aggressive non‐Hodgkin lymphomas

Churpek, Jane E. ; Pro, Barbara ; van Besien, Koen ; Kline, Justin ; Conner, Kathy ; Wade, James L. ; Hagemeister, Fredrick ; Karrison, Theodore ; Smith, Sonali M.

Cancer, 2013-05, Vol.119 (9), p.1683-1689 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
5
AAML0523: A report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia
AAML0523: A report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

AAML0523: A report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia

Cooper, Todd M. ; Alonzo, Todd A. ; Gerbing, Robert B. ; Perentesis, John P. ; Whitlock, James A. ; Taub, Jeffrey W. ; Horton, Terzah M. ; Gamis, Alan S. ; Meshinchi, Soheil ; Loken, Michael R. ; Razzouk, Bassem I.

Cancer, 2014-08, Vol.120 (16), p.2482-2489 [Periódico revisado por pares]

Hoboken, NJ: Wiley-Blackwell

Texto completo disponível

Citações Citado por
6
Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome‐related burkitt lymphoma/leukemia
Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome‐related burkitt lymphoma/leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome‐related burkitt lymphoma/leukemia

Cortes, Jorge ; Thomas, Deborah ; Rios, Adan ; Koller, Charles ; O'Brien, Susan ; Jeha, Sima ; Faderl, Stefan ; Kantarjian, Hagop

Cancer, 2002-03, Vol.94 (5), p.1492-1499 [Periódico revisado por pares]

New York: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
7
Impact of pre‐transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation
Impact of pre‐transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impact of pre‐transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation

El‐Jawahri, Areej ; Chen, Yi‐Bin ; Brazauskas, Ruta ; He, Naya ; Lee, Stephanie J. ; Knight, Jennifer M. ; Majhail, Navneet ; Buchbinder, David ; Schears, Raquel M. ; Wirk, Baldeep M. ; Wood, William A. ; Ahmed, Ibrahim ; Aljurf, Mahmoud ; Szer, Jeff ; Beattie, Sara M. ; Battiwalla, Minoo ; Dandoy, Christopher ; Diaz, Miguel‐Angel ; D'Souza, Anita ; Freytes, Cesar O. ; Gajewski, James ; Gergis, Usama ; Hashmi, Shahrukh K. ; Jakubowski, Ann ; Kamble, Rammurti T. ; Kindwall‐Keller, Tamila ; Lazarus, Hilard M. ; Malone, Adriana K. ; Marks, David I. ; Meehan, Kenneth ; Savani, Bipin N. ; Olsson, Richard F. ; Rizzieri, David ; Steinberg, Amir ; Speckhart, Dawn ; Szwajcer, David ; Schoemans, Helene ; Seo, Sachiko ; Ustun, Celalettin ; Atsuta, Yoshiko ; Dalal, Jignesh ; Sales‐Bonfim, Carmem ; Khera, Nandita ; Hahn, Theresa ; Saber, Wael

Cancer, 2017-05, Vol.123 (10), p.1828-1838 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
8
Routine clinical use of alemtuzumab in patients with heavily pretreated B‐cell chronic lymphocytic leukemia
Routine clinical use of alemtuzumab in patients with heavily pretreated B‐cell chronic lymphocytic leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Routine clinical use of alemtuzumab in patients with heavily pretreated B‐cell chronic lymphocytic leukemia

Fiegl, Michael ; Falkner, Andreas ; Hopfinger, Georg ; Brugger, Stefan ; Zabernigg, August ; Bauer, Franz ; Haslbauer, Ferdinand ; Demirtas, Dita ; Grossschmidt, Peter ; Tatzreiter, Georg ; Gastl, Günther ; Greil, Richard

Cancer, 2006-11, Vol.107 (10), p.2408-2416 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
9
Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States
Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States
Material Type:
Artigo 		Adicionar ao Meu Espaço

Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States

Hong, Sanghee ; Brazauskas, Ruta ; Hebert, Kyle M. ; Ganguly, Siddhartha ; Abdel‐Azim, Hisham ; Diaz, Miguel Angel ; Beattie, Sara ; Ciurea, Stefan O. ; Szwajcer, David ; Badawy, Sherif M. ; Gratwohl, Alois A. ; LeMaistre, Charles ; Aljurf, Mahmoud D. S. M. ; Olsson, Richard F. ; Bhatt, Neel S. ; Farhadfar, Nosha ; Yared, Jean A. ; Yoshimi, Ayami ; Seo, Sachiko ; Gergis, Usama ; Beitinjaneh, Amer M. ; Sharma, Akshay ; Lazarus, Hillard ; Law, Jason ; Ulrickson, Matthew ; Hashem, Hasan ; Schoemans, Hélène ; Cerny, Jan ; Rizzieri, David ; Savani, Bipin N. ; Kamble, Rammurti T. ; Shaw, Bronwen E. ; Khera, Nandita ; Wood, William A. ; Hashmi, Shahrukh ; Hahn, Theresa ; Lee, Stephanie J. ; Rizzo, J. Douglas ; Majhail, Navneet S. ; Saber, Wael

Cancer, 2021-02, Vol.127 (4), p.609-618 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
10
Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States
Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States
Material Type:
Artigo 		Adicionar ao Meu Espaço

Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States

Hong, Sanghee ; Brazauskas, Ruta ; Hebert, Kyle M ; Ganguly, Siddhartha ; Abdel-Azim, Hisham ; Diaz, Miguel Angel ; Beattie, Sara ; Ciurea, Stefan O ; Szwajcer, David ; Badawy, Sherif M ; Gratwohl, Alois A ; LeMaistre, Charles ; Aljurf, Mahmoud D.S.M ; Olsson, Richard F ; Bhatt, Neel S ; Farhadfar, Nosha ; Yared, Jean A ; Yoshimi, Ayami ; Seo, Sachiko ; Gergis, Usama ; Beitinjaneh, Amer M ; Sharma, Akshay ; Lazarus, Hillard ; Law, Jason ; Ulrickson, Matthew ; Hashem, Hasan ; Schoemans, Helene ; Cerny, Jan ; Rizzieri, David ; Savani, Bipin N ; Kamble, Rammurti T ; Shaw, Bronwen E ; Khera, Nandita ; Wood, William A ; Hashmi, Shahrukh ; Hahn, Theresa ; Lee, Stephanie J ; Rizzo, J. Douglas ; Majhail, Navneet S ; Saber, Wael

CANCER, 2020-10, Vol.127 (4), p.609-618 [Periódico revisado por pares]

WILEY

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.